Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

LACTATE DEHYDROGENASE (LDH) - ANVISA Registration 10347320370

Access comprehensive regulatory information for LACTATE DEHYDROGENASE (LDH) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10347320370 and manufactured by HORIBA INSTRUMENTS BRASIL LTDA. The registration is held by HORIBA INSTRUMENTS BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
10347320370
2 Related Devices
Registration Details
ANVISA Registration Number: 10347320370
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

HORIBA POINTE LACTATE DEHYDROGENASE
Risk Class II

Registration Details

10347320370

25351514971202388

01759236000179

Company Information

Brazil
PT: BRASIL

Dates and Status

Sep 04, 2023

VIGENTE

09/18/2025 19:00:01

HORIBA POINTE LACTATE DEHYDROGENASE
Risk Class II

Registration Details

10347320370

25351514971202388

01759236000179

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Sep 04, 2023

VIGENTE

09/18/2025 19:00:01